Canaccord Genuity Reiterates a 'Buy' on Gen-Probe (GPRO); HPV Garnering Attention
Tweet
Share
E-mailGet Alerts GPRO Hot Sheet
Price: $0.63 +1.61%
Rating Summary:
4 Buy, 11 Hold, 6 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
4 Buy, 11 Hold, 6 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Canaccord Genuity reiterates a 'Buy' on Gen-Probe (NASDAQ: GPRO) price target of $67.00.
Canaccord analyst says, "We reiterate our rating following some time recently spent with management, which reinforced our views of a high value pipeline...HPV execution now the focus. Following last month’s approval of its HPV test, GPRO started receiving orders; however, sales will lag a few months for validations. In our opinion, GPRO’s improved false positive rate may provide physicians with increased comfort and increased utilization."
For an analyst ratings summary and ratings history on Gen-Probe click here. For more ratings news on Gen-Probe click here.
Shares of Gen-Probe closed at $61.12 yesterday.
Canaccord analyst says, "We reiterate our rating following some time recently spent with management, which reinforced our views of a high value pipeline...HPV execution now the focus. Following last month’s approval of its HPV test, GPRO started receiving orders; however, sales will lag a few months for validations. In our opinion, GPRO’s improved false positive rate may provide physicians with increased comfort and increased utilization."
For an analyst ratings summary and ratings history on Gen-Probe click here. For more ratings news on Gen-Probe click here.
Shares of Gen-Probe closed at $61.12 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GoPro promotes CFO Brian Tratt to senior vice president role
- Benchmark Reiterates Buy Rating on Rank One Computing (ROC)
- DA Davidson Reiterates Buy Rating on Box, Inc. (BOX) on Secular Tailwinds for Demand
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
